Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 16, 2026
Sterling doubles ADC capacity at its Welsh facility
The Deeside expansion adds a 500-liter reactor, a cleanroom and analytical lab capacity.
Today in brief
Sterling Pharma Solutions has doubled manufacturing capacity at its Deeside bioconjugation facility and increased batch scale with a multi-million-pound expansion.1 The new GMP suite includes a 500-liter reactor and Grade C cleanroom, while an expanded analytical lab adds capacity for chromatography and cell assay work.1 Sterling said the suite is available immediately for customer projects.1
Also published
- Hospital financial pressure is reshaping how we think about supply chain resilience pharmaphorum
- Domestic Manufacturing Is a Meaningful But Incomplete Answer Pharmaceutical Executive
- The Impact That the Renewed Focus on Domestic Manufacturing Might Have on the Supply Chain Pharmaceutical Executive